Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s56370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

2013English

Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

Progress in Tumor Research
Cancer ResearchOncology
2014English

Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Therapies: A Single Institution Experience

Clinical Genitourinary Cancer
OncologyUrology
2014English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Clinical and Pathologic Impact of Select Chromatin-Modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma

European Urology
Urology
2013English

Myoferlin Silencing Inhibits VEGFR2-mediated Proliferation of Metastatic Clear Cell Renal Cell Carcinoma

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy